Qiang Ma

Dr. Qiang Ma

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2018 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
HZHao Zhou
Hao Zhou
DLDandan Li
Dandan Li
PZPingjun Zhu
Pingjun Zhu
QMQiang Ma
Qiang Ma
STSam Toan
Sam Toan
YZYingmei Zhang
Yingmei Zhang

24 January 2018 in Journal of Pineal Research
Verified
Journal Article
Open access
PDF file
HZHao Zhou
Hao Zhou
QMQiang Ma
Qiang Ma
PZPingjun Zhu
Pingjun Zhu
JRJun Ren
Jun Ren
Russel ReiterRussel Reiter
Russel Reiter
YCYundai Chen
Yundai Chen
Acute myocardial infarction (MI) is a major cause of mortality and disability worldwide. In patients withMI, the treatment option for reducing acute myocardial ischemic injury and limitingMIsize is timely and effective myocardial reperfusion using either thombolytic therapy or primary percutaneous coronary intervention (PCI). However, the procedure of reperfusion itself induces cardiomyocyte death, known as myocardial reperfusion injury, for which there is still no effective therapy. Recent evidence has depicted a promising role of melatonin, which possesses powerful antioxidative and anti‐inflammatory properties, in the prevention of ischemia‐reperfusion (IR) injury and the protection against cardiomyocyte death. A number of reports explored the mechanism of action behind melatonin‐induced beneficial effects against myocardialIRinjury. In this review, we summarize the research progress related toIRinjury and discuss the unique actions of melatonin as a protective agent. Furthermore, the possible mechanisms responsible for the myocardial benefits of melatonin against reperfusion injury are listed with the prospect of the use of melatonin in clinical application.

19 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Jia-qing ZhangJia-qing Zhang
Jia-qing Zhang
BGBin-Wen Gao
Bin-Wen Gao
JWJing Wang
Jing Wang
QRQiao-Ling Ren
Qiao-Ling Ren
JCJun-Feng Chen
Jun-Feng Chen
BXBao-Song Xing
Bao-Song Xing
Reactive oxygen species (ROS) are closely related to the follicular granulosa cell apoptosis. Grape seed procyanidin B2 (GSPB2) has been reported to possess potent antioxidant activity. However, the GSPB2‐mediated protective effects and the underlying molecular mechanisms in granulosa cell apoptosis process remain unknown. In this study, we showed for the first time that GSPB2 treatment decreased FoxO1 protein level, improved granulosa cell viability, upregulated LC3‐II protein level, and reduced granulosa cell apoptosis rate. Under a condition of oxidative stress, GSPB2 reversed FoxO1 nuclear localization and increased its level in cytoplasm. In addition, FoxO1 knockdown inhibited the protective effects of GSPB2 induced. Our findings suggest that FoxO1 plays a pivotal role in regulating autophagy in granulosa cells, GSPB2 exerts a potent and beneficial role in reducing granulosa cell apoptosis and inducing autophagy process, and targeting FoxO1 could be significant in fighting against oxidative stress‐reduced female reproductive system diseases.

1 February 2018 in Stem Cells
Verified
Journal Article
Open access
PDF file
QMQiang Ma
Qiang Ma
JYJunjie Yang
Junjie Yang
XHXu Huang
Xu Huang
WGWeisheng Guo
Weisheng Guo
SLSulei Li
Sulei Li
YCYundai Chen
Yundai Chen
Stem cell transplantation is a promising therapeutic strategy for myocardial infarction. However, transplanted cells face low survival rates due to oxidative stress and the inflammatory microenvironment in ischemic heart tissue. Melatonin has been used as a powerful endogenous antioxidant to protect cells from oxidative injury. However, melatonin cannot play a long-lasting effect against the hostile microenvironment. Nano drug delivery carriers have the ability to protect the loaded drug from degradation in physiological environments in a controlled manner, which results in longer effects and decreased side effects. Therefore, we constructed poly(lactide-co-glycolide)-monomethoxy-poly-(polyethylene glycol) (PLGA-mPEG) nanoparticles to encapsulate melatonin. We tested whether the protective effect of melatonin encapsulated by PLGA-mPEG nanoparticles (melatonin nanoparticles [Mel-NPs]) on adipose-derived mesenchymal stem cells (ADSCs) was enhanced compared to that of free melatonin both in vitro and in vivo. In the in vitro study, we found that Mel-NPs reduced formation of the p53- cyclophilin D complex, prevented mitochondrial permeability transition pores from opening, and rescued ADSCs from hypoxia/reoxygenation injury. Moreover, Mel-NPs can achieve higher ADSC survival rates than free melatonin in rat myocardial infarction areas, and the therapeutic effects of ADSCs pretreated with Mel-NPs were more apparent. Hence, the combination of Mel-NPs and stem cell transplantation may be a promising strategy for myocardial infarction therapy.

27 September 2021 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
ZLZhi-Wei Liu
Zhi-Wei Liu
QMQiang Ma
Qiang Ma
JLJie Liu
Jie Liu
JLJing-Wei Li
Jing-Wei Li
YCYundai Chen
Yundai Chen
Background: Furin is the key enzyme involved in the cleavage of pro-BNP and plays a critical role in the cardiovascular system through its involvement in lipid metabolism, blood pressure regulation and the formation of atheromatous plaques. NT-proBNP and recently, corin, also a key enzyme in the cleavage of pro-BNP, have been accepted as predictors of prognosis after acute myocardial infarction (AMI). This cohort study was conducted to investigate the relationship between plasma furin and the prognostic outcomes of AMI patients. Methods: In total, 1100 AMI patients were enrolled in the study and their plasma furin concentrations were measured. The primary endpoint was major adverse cardiac events (MACE), a composite of cardiovascular (CV) death, non-fatal myocardial infarction (MI) and non-fatal stroke. The associations between plasma furin concentration and AMI outcomes were explored using Kaplan–Meier curves and multivariate Cox regression analysis. Results: The results showed a slight increase in mean cTNT in patients with higher furin concentrations (P = 0.016). Over a median follow-up of 31 months, multivariate Cox regression analysis indicated that plasma furin was not significantly associated with MACE (HR 1.01; 95% CI 0.93–1.06; P = 0.807) after adjustment for potential conventional risk factors. However, plasma furin was associated with non-fatal MI (HR 1.09; 95% CI 1.01–1.17; P = 0.022) in the fully adjusted model. Subgroup analyses indicated no relationship between plasma furin and MACE in different subgroups. Conclusions: This study found no association between plasma furin and risk of MACE. Thus, plasma furin may not be a useful predictor of poor prognosis after AMI. However, higher levels of plasma furin may be associated with a higher risk of recurrent non-fatal MI.

28 July 2025 in Respiratory Investigation
Verified
Journal Article
Closed access
PCPeiruo Chen
Peiruo Chen
ZHZhihai Han
Zhihai Han
QMQiang Ma
Qiang Ma